Skip to content

Vogenx (VOGX) IPO deck

Vogenx is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and gastrointestinal disorders.

This post is for paying subscribers only

Subscribe

Already have an account? Sign In

Latest